✦ LIBER ✦

Efficacy of fenofibrate in Chinese patients with primary biliary cirrhosis partially responding to ursodeoxycholic acid therapy

✍ Scribed by Xiao Feng HAN; Qi Xia WANG; Yuan LIU; Zheng Rui YOU; Zhao Lian BIAN; De Kai QIU; Xiong MA

Book ID: 114897763
Publisher: Wiley (Blackwell Publishing)
Year: 2012
Tongue: English
Weight: 511 KB
Volume: 13
Category: Article
ISSN: 1751-2972
DOI: 10.1111/j.1751-2980.2012.00574.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Positive responses to methotrexate and u

Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone

✍ Hans-Peter Buscher; Yvonne Zietzschmann; Wolfgang Gerok 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 471 KB

Immunomodulating effect of ursodeoxychol

Immunomodulating effect of ursodeoxycholic acid therapy in patients with primary biliary cirrhosis

✍ D. Kürktschiev; S. Subat; D. Adler; K.-U. Schentke 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Triple therapy with ursodeoxycholic acid

Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone

✍ Rabahi, N.; Chrétien, Y.; Gaouar, F.; Wendum, D.; Serfaty, L.; Chazouillères, O. 📂 Article 📅 2010 🏛 Masson Editeur 🌐 French ⚖ 201 KB

Pilot study: fenofibrate for patients wi

Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid

✍ C. Levy; J. A. Peter; D. R. Nelson; J. Keach; J. Petz; R. Cabrera; V. Clark; R. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

Methotrexate therapy for the symptomatic

Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy

✍ M. A. BABATIN; F. M. SANAI; M. G. SWAIN 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB

Cholesterol-lowering effect of ursodeoxy

Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis

✍ Renée E. Poupon; Khadija Ouguerram; Yves Chrétien; Claudine Verneau; Eveline Esc 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 591 KB

We have previously shown in a 2-yr controlled trial that hypercholesterolemia, frequent in primary biliary cirrhosis, is lowered by ursodeoxycholic acid (13 to 15 mg daily). To further investigate this effect, we analyzed the influence of long-term ursodeoxycholic acid administration on serum lipids